Sinomarin

Quick links to important sections

Sinomarin

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Sinomarin

Quick Facts

Property Description
Active ingredient Sea water (functionally Sodium Chloride Solution)
Form Nasal spray, Solution in vials
Pharmacological class Nasal Lubricants and Irrigations / Natural Decongestant
Common use Relief of nasal congestion and cleansing
Origin Natural (Derived from high-quality Sea water)

Identity: What is Sinomarin Hypertonic Sea Water Solution?

Sinomarin is a Hypertonic Sea Water Solution, a natural product for intranasal use that functions as a natural nasal decongestant and nasal irrigation agent. Manufactured by Gerolymatos International, it is positioned globally as an Over-the-Counter (OTC) product. It is regulated as a CE-Mark-bearing medical device (Class II), a classification signifying that its primary mode of action is physical rather than pharmacological. Its general classification falls within the category of nasal lubricants and irrigations.

Composition: What is Sinomarin Made of?

The solution is natural and consists of Sea water and Purified water, containing no synthetic drugs, preservatives, or chemical additives. The functional component is its hypertonic salt concentration, where the Sodium Chloride (NaCl) level is standardized at 2.3% NaCl. This concentration differentiates the product from isotonic saline solutions, which are primarily used for moisturizing. The Sea water source naturally provides a complement of mineral salts and trace elements.

General Purpose: Why Use a Hypertonic Solution?

The primary purpose of this Hypertonic Sea Water Solution is to help alleviate nasal congestion and sinus pressure through a non-pharmacological mechanism. The process relies on osmotic decongestion, where the salt concentration physically draws excess water from swollen nasal tissues, thereby reducing edema. In addition to the osmotic action, the solution provides mechanical cleansing, which aids in the removal of accumulated mucus and environmental irritants, supporting overall nasal hygiene and mucociliary clearance.

Regulatory References

  1. Hypertonic Saline Nasal Irrigation Studies (PubMed/NIH)

What side effects are possible with Sinomarin?

The safety characteristics of Sinomarin are consistent with its classification as a non-pharmacological hypertonic sea water solution and a Medical Device. The adverse reaction profile is limited to the site of application (the nasal mucosa), as the solution is not systemically absorbed.

Documented Adverse Reactions

Adverse effects are documented as local, mild, and transient. The physical sensation of the hypertonic concentration may lead to minor discomfort classified within the Respiratory, thoracic and mediastinal system organ class:

  • A mild and temporary stinging sensation in the nasal cavity.
  • Transient irritation of the nasal lining.
  • Sneezing following application.

These sensations are noted in official labeling as more likely to be experienced at the beginning of use but typically subside rapidly. The regulatory safety data confirms the absence of documented serious adverse reactions with this formulation.

Population Safety and Restrictions

Due to the lack of systemic drug components, this solution is noted as suitable for use during pregnancy, breastfeeding, and in pediatric patients (with appropriate applicators). This suitability also extends to individuals with underlying conditions, such as high blood pressure, where medicated decongestants are restricted.

High-level safety constraints include advising against use in individuals with a known sensitivity or allergy to any of the product's natural components. Furthermore, the labeling includes a constraint against sharing the applicator to prevent the potential for cross-infection.

Overdose and Emergency Response

Overdose and When to Seek Help

The official overdose profile for Sinomarin, a hypertonic sea water solution, reflects its classification as a non-pharmacologically active medical device. Overdose is generally not expected to be dangerous when the product is used as intended via the nasal route.

Category Official Regulatory Documentation
Documented Manifestations Excessive topical use may lead to transient local irritation, dryness, or tingling within the nasal cavity.
Antidote Availability No specific antidote is known, consistent with the product's composition of water and salt.
Supportive Management Treatment for overdose is symptomatic and supportive. In the event of severe accidental ingestion, health monitoring, including of serum electrolytes, may be required to manage potential solute overload.

When to Seek Urgent Medical Attention

Regulatory documentation mandates specific actions for unintended exposure. Immediate help must be sought if the product is accidentally swallowed, particularly in large quantities. In such cases, one must seek emergency medical attention or call the Poison Help line for guidance on managing the risk of systemic effects, such as potential hypernatremia or electrolyte imbalance. This guidance on massive ingestion is especially relevant for children, where the risk from concentrated salt is a consideration. The official instructions focus on the consequences of accidental ingestion, rather than pharmacological toxicity from nasal application.

Therapeutic Uses of Sinomarin

What Sinomarin Treats: Main Uses and Benefits


The fundamental purpose of using a hypertonic sea water solution is to provide supportive relief in conditions characterized by periods of heightened symptoms affecting the nasal cavity. Nasal irrigation generally helps remove excess mucus and irritants while adding moisture.

Symptomatic Relief and Therapeutic Scope

This solution is commonly used in clinical settings that involve acute or disruptive symptom patterns, particularly for relief of nasal congestion, sinus pressure, and the management of excessive or thick mucus secretions. It is applied across conditions such as the common cold, flu, acute rhinosinusitis, and both seasonal and perennial allergic rhinitis.

The therapeutic benefit is realized in easing the symptoms related to physical discomfort and functional strain. The solution contributes to easing the overall symptom load through the effective clearance of thick secretions and airborne irritants, and may help patients cope more steadily with symptom fluctuations. It is considered relevant when short-term symptomatic assistance is needed across various patient groups, including infants, children, and pregnant or breastfeeding women.

“The primary goal is symptom management, aiming to support general well-being during symptomatic phases.”


Therapeutic Focus: Nasal Congestion and Mucus Build-up Management

Regulatory References

  1. NIH MedlinePlus overview on Saline Nasal Washes

Eligibility and Restrictions for Use

Sinomarin is a drug-free, non-pharmacological solution, and its eligibility profile is primarily determined by its CE-Marked Medical Device classification, which minimizes systemic restrictions.

Populations Not Eligible (Contraindications)

Use is contraindicated in patients with a documented hypersensitivity or allergy to sea water or any other component of the specific product formulation. Additionally, use is restricted to individuals at or above the minimum age designated on the product label.

Age and Product Eligibility

Age eligibility varies significantly by product line: specific Baby and Mini formulations are labeled for use starting at 0+ months (Newborns), while standard Adult products are typically for those 6+ years and older. Certain specialized jet sprays may carry an even higher minimum age threshold, such as 12+ years.

Special Population Status

Due to its composition, the core hypertonic solution is officially documented as suitable for use by pregnant and breastfeeding women. The official regulatory profile does not contain restrictions based on systemic organ function, such as hepatic or renal impairment. This non-pharmacological status makes the core product an eligible option for individuals with conditions that typically restrict medicated decongestants, including hypertension or diabetes.

What should I know about interactions with other medicines?

Official Interaction Profile

Sinomarin Hypertonic Sea Water Solution is a medical device and not a pharmaceutical drug; consequently, its official regulatory profile for interactions differs significantly from that of pharmacologically active medicines. The product's composition—consisting exclusively of natural sea water and purified water—precludes the potential for systemic drug-drug interactions.

Pharmacological Interaction Status

Interaction Type Regulatory Position Constraint/Note
Systemic Metabolism (CYP) None documented Lack of systemic absorption means no risk of enzyme-mediated pharmacokinetic interference.
Contraindicated Combinations None documented No formal drug-drug combinations are listed as contraindicated in regulatory documents.
Timing Requirements None documented No mandatory time separation is required when used alongside other local treatments.

Documented Co-Administration

The primary interaction context established in official product information is one of supportive co-administration. The solution is documented as suitable for use in conjunction with medicated treatments (such as local corticosteroids, antihistamines, or vasoconstrictors). This is considered a non-pharmacological, supportive effect intended to assist the optimal application and action of the co-administered treatments by physically cleansing the nasal cavity. No interactions with food, alcohol, or supplements are documented.

Mechanism of Action

Mechanism of Action

Sinomarin's function is driven by three distinct mechanisms that modulate local physiological processes within the nasal mucosa.

  1. Osmotic Decongestant Action: The hypertonic solution creates a defined osmotic gradient across the semi-permeable mucosal lining. This induces exosmosis, a physical process that draws excess interstitial water out of the edematous tissue. This consequence is a reduction of edema volume which mechanically increases the cross-sectional area of the nasal passage.

  2. Modulating Mucociliary Dynamics: Through hydration and mineral exchange, the solution influences the rheological properties of the viscous secretions, facilitating their fluidification. This biophysical effect supports the coordinated movement of the cilia, aiding in the effective clearance of the mucus blanket and supporting the natural clearance mechanism.

  3. Mechanical Cleansing and Barrier Support: The solution provides a mechanical washing action, physically flushing accumulated environmental pollutants and biological debris from the epithelial surface. This action reduces the physical presence of irritants that engage inflammatory signaling pathways, thereby supporting the overall stability and integrity of the nasal epithelial barrier.

Dosage and Administration Information

Instruction Map: How to use Sinomarin — Official Administration Guidelines


Administration Scope

Entity Instruction
Route of administration The product is administered through the intranasal route as a spray or drops. Certain specialized solutions are also cleared for inhaled administration via nebulizer.
Dosing schedule Adults and Children ≥ 6 years: 1 to 3 sprays in each nostril. Infants ≥ 1 month: A few drops or a maximum of one vial in each nostril, with volume adjusted for age.
Timing in relation to meals (if applicable) Official instructions do not state any requirement for use in relation to meals.
Preparation requirements (if applicable) The nasal cavity must be cleared of mucus (e.g., by blowing the nose) immediately prior to application. The ready-to-use spray pump may require priming (initial activation sprays) before first use.
Age-group administration rules Explicit volume and frequency adjustments are defined for Infants/Babies (≥ 1 month). The solution is suitable for use during pregnancy and breastfeeding.
Missed-dose rules Formal missed-dose instructions are generally not provided for this type of medical device.
Special procedural conditions The solution is utilized in the context of postoperative irrigation. The applicator must be cleaned after each use and sharing is prohibited to maintain hygiene.

Instruction Classifications (High-Level)

Classification Principle
Administration method type Topical (Intranasal) and Inhaled (via nebulizer).
Frequency pattern Multiple times daily (typically 2 to 3 times daily), reflecting an intermittent usage pattern over a specified duration.
Regulatory basis Official Product Labeling (Instructions for Use for a CE-Marked Medical Device).
Use-context constraints Must be used with appropriate hygiene. Specific product variants are labeled for uninterrupted use for up to 30 days.

Resulting Procedural Structure

Official step sequence:

  • Pre-administration: Clear the nasal cavity of mucus.
  • Dosing: Deliver the prescribed volume (1 to 3 sprays or drops/vial) into each nostril, according to the specific age instructions.
  • Post-administration: Allow the solution to act for a short duration before clearing the nose again.
  • Hygiene: Clean the nozzle thoroughly after the use and before storage.

Connection to the overall use protocol:

This protocol establishes the standardized use of the hypertonic solution by defining the intranasal delivery route and the corresponding age-specific volume controls for application. The instructions mandate a clear pre-administration step (clearing the nose) and strict post-use hygiene to ensure consistency and proper maintenance of the device.

Recent Clinical Evidence

Sinomarin: Recent Clinical Evidence

This section summarizes the key research evidence that has evaluated Sinomarin, a hypertonic sea water solution.


Overview of Clinical Research

Studies have explored the use of Sinomarin in participants reporting symptoms related to nasal congestion and rhinitis. Early clinical trials focused on short-term outcomes, examining the results of treatment over initial usage periods. Follow-up research explored whether the observed outcomes persisted following a fixed treatment duration.

Studies have evaluated Sinomarin in participants across various age groups, including children and adults. In pediatric trials, research explored the effect of the solution on the clearance of mucus and nasal blockage. For adult conditions, studies examined the tolerability and subjective symptom reduction following regular administration.


Specialized Studies and Indications

Research has specifically examined the use of hypertonic sea water solutions in populations with chronic conditions, such as chronic rhinosinusitis. These studies evaluated whether Sinomarin impacts patient-reported quality of life measures, using standardized questionnaires to assess the burden of nasal symptoms.

In studies involving acute respiratory tract infections, Sinomarin was evaluated in combination with other existing treatments. The research examined whether the combined approach affected the duration or severity of reported symptoms compared to other treatments. Limited data suggests a focus on physical parameters like nasal resistance, rather than therapeutic claims.

Research has explored the tolerability profile across different dosing schedules. Studies have investigated the incidence of local side effects, such as temporary irritation or dryness, noting that findings were generally well-documented within the studied populations.

Frequently Asked Questions (FAQ)

Common questions about Sinomarin (FAQ)


Q: Is Sinomarin the same as a normal saline spray?

A: According to official product documentation, Sinomarin is defined as a hypertonic sea water solution. This means it has a higher salt concentration, typically 2.3% NaCl, which is significantly greater than the standard isotonic saline concentration of about 0.9% NaCl found in a normal saline spray. This difference in concentration provides its physical mechanism for relieving congestion.


Q: What is the main difference between Sinomarin and a standard nasal wash?

A: The key difference is functional, stemming from the solution’s high salt concentration. As a hypertonic solution, Sinomarin is physically designed to draw excess water out of swollen nasal tissue through a process called osmosis, which is associated with the relief of nasal congestion. Standard nasal washes are typically isotonic and are primarily used for general moisturizing and rinsing.


Q: Why does Sinomarin feel stronger than other nasal sprays?

A: Official safety information notes that due to the high hypertonic salt concentration, users may experience a mild and temporary stinging sensation or localized irritation inside the nose. This physical sensation is generally transient and is a documented characteristic related to the product’s action, particularly when use is first initiated.


Q: Is Sinomarin for long-term or short-term use?

A: Sinomarin is a non-pharmacological solution generally intended for intermittent usage over a specified duration. Instructions for specific product lines may reference a maximum continuous use period, such as up to 30 days. The official documentation defines its frequency pattern as multiple times daily.


Q: Is it possible to use Sinomarin too much?

A: The official product labeling provides specific frequency guidelines, such as typically 2 to 3 times daily (depending on the product line). The instructions state the product should be used within these defined parameters.


Q: Does Sinomarin contain preservatives?

A: Official product information confirms that the composition of the core Sinomarin solution is entirely natural and is documented as being preservative-free. It also contains no synthetic drugs or chemical additives.


Q: Are there specific instructions for infants using Sinomarin?

A: Specific product variants are labeled for use in infants as young as one month old. These products include specialized applicators and feature volume adjustments defined in the age-group administration rules.


Q: Can Sinomarin be used for allergies?

A: Specific variants of the Sinomarin product line are officially labeled for use in relieving nasal symptoms associated with seasonal or chronic allergies (allergic rhinitis). The solution provides a cleansing action that contributes to the physical washing out of irritants and allergens from the nasal passages.


Q: Does Sinomarin help with post-nasal drip?

A: The product's mechanism of action involves hydrating and thinning thick mucus secretions to aid in their fluidification and clearance. This physical effect supports the elimination of excess secretions, which may be relevant to the symptoms associated with post-nasal drip.


Q: Is Sinomarin effective for a common cold?

A: Specific formulations of the product line are labeled for use in providing relief from nasal symptoms associated with infectious rhinitis, which includes the common cold and flu. It works by clearing congestion and helping to wash out impurities.


Q: Do you need a prescription to buy Sinomarin?

A: The product is generally classified and distributed as an Over-The-Counter (OTC) product. This classification means it is available for purchase without a prescription.


Q: Does Sinomarin cause rebound congestion?

A: Official product information for the non-medicated hypertonic solution states that it does not cause habit formation or rebound effect (rebound congestion). This characteristic is attributed to its physical, non-pharmacological mode of action, as documented in regulatory safety data.


Q: Can Sinomarin be used for ear problems related to the nose?

A: The core product is labeled exclusively for intranasal use. However, the manufacturer's product line includes a separate formulation that is specifically labeled for use as an ear cleansing spray to aid in ear hygiene.


Q: Is it common for people to get headaches after using Sinomarin?

A: Headaches are not listed among the documented adverse reactions in the official safety profile. The documented adverse effects are limited to mild, transient, and local effects such as temporary stinging or irritation at the application site.


Q: Does Sinomarin clean out allergens from the nasal passages?

A: The solution's mechanical cleansing action physically supports the washing out of impurities and environmental irritants, including allergens, from the nasal passages.


Q: Is there an expiry date on Sinomarin that needs to be watched?

A: Official product precautions state that the product should not be used past the expiry date printed on the packaging. Specific product packaging may also provide guidance regarding the period after opening (PAO).


Q: Can Sinomarin be used alongside antibiotics?

A: Official documentation indicates that the non-pharmacological product is suitable for use alone or in combination with medicated treatments, which would include antibiotics. It is noted that the product has no documented systemic drug-drug interactions.


Q: What does official documentation say about the purity of the seawater in Sinomarin?

A: The product documentation describes the seawater source as being from an area known for its quality and renewal. The information states that the seawater is unquestionably pure and its quality guaranteed and that the product complies with CE-Mark quality requirements.


Q: How does the concentration of salt in Sinomarin compare to normal body fluids?

A: The salt concentration in Sinomarin is standardized at 2.3% NaCl. This concentration is hypertonic, meaning it is greater than the salt concentration found in normal human body fluids, which is approximately 0.9% NaCl (isotonic).


Q: Is Sinomarin suitable for people with chronic rhinitis?

A: The product is indicated for the relief of nasal congestion and cleansing. Its action in clearing mucus and supporting the nasal barrier is documented to address symptoms commonly associated with rhinitis. Specific variants are also indicated in the context of chronic conditions like chronic rhinosinusitis.


Q: What kind of studies are available about Sinomarin's use in children?

A: Research summaries indicate that studies have been conducted to evaluate the effect of the hypertonic solution in pediatric patients. The research explored key outcomes such as the effectiveness in promoting the clearance of mucus and the reduction of nasal blockage in children.

How should Sinomarin be stored and disposed of?

Sinomarin nasal spray should be stored at room temperature, generally between 15 C and 25 C (59 F and 77 F), unless otherwise specified on the packaging. It is important to protect the container from direct sunlight, moisture, and excessive heat.

For pressurized nasal spray containers, they are typically protected from temperatures exceeding 50 C (122 F) and must not be punctured or incinerated, even when empty. Always keep this product out of the reach of children and pets.

Disposal Table

Condition Action
Expired or Unused Product Do not dispose of in household trash or flush down a toilet. Consult a pharmacist for guidance on local pharmaceutical take-back or disposal programs.
Damaged Container Do not use; dispose of following local guidelines for safe pharmaceutical waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Sinomarin found in:

A-Z Index: